Drugs / AST-021p
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04864418 | Jun 2021 → Aug 2023 | cancer of unknown primary site | Aston Sci. Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AST-021p | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04864418 ↗ |
| Modality | Vaccine | “Therapeutic Cancer Vaccine (AST-021p)” NCT04864418 ↗ |